SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Biochemical Pharmacology Année : 2023

SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?

Résumé

Ion channels are transmembrane structures that allow the passage of ions across cell membranes such as the plasma membrane or the membranes of various organelles like the nucleus, endoplasmic reticulum, Golgi apparatus or mitochondria. Aberrant expression of various ion channels has been demonstrated in several tumor cells, leading to the promotion of key functions in tumor development, such as cell proliferation, resistance to apoptosis, angiogenesis, invasion and metastasis. The link between ion channels and these key biological functions that promote tumor development has led to the classification of cancers as oncochannelopathies. Among all ion channels, the most varied and numerous, forming the largest family, are the potassium channels, with over 70 genes encoding them in humans. In this context, this review will provide a non-exhaustive overview of the role of plasma membrane potassium channels in cancer, describing 1) the nomenclature and structure of potassium channels, 2) the role of these channels in the control of biological functions that promotes tumor development such as proliferation, migration and cell death, and 3) the role of two particular classes of potassium channels, the SKCa- and Kv1- type potassium channels in cancer progression.

Dates et versions

hal-04425219 , version 1 (29-01-2024)

Identifiants

Citer

Maryne Dupuy, Maxime Gueguinou, Marie Potier-Cartereau, Frédéric Lézot, Marion Papin, et al.. SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?. Biochemical Pharmacology, 2023, 216, pp.115774. ⟨10.1016/j.bcp.2023.115774⟩. ⟨hal-04425219⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More